News
MIMETAS in the global news. Read more about our latest research, developments, collaborations, and product launches.
Sign up for our newsletter to stay up to date.
MIMETAS Participates in €124.5 million Initiative to Transition to Animal-free Innovation
MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet
Innovative Gut-on-a-Chip Platform Paves the Way for Enterotoxin Research Breakthroughs
MIMETAS participates in GRIPonMASH initiative to improve prevention and care of Metabolic dysfunction-Associated Steatohepatitis (MASH)
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
Microfluidic Models of the Neurovascular Unit: A Translational View
MIMETAS Co-CEO, Paul Vulto, nominated as new Netherlands Academy of Engineering Fellow
Human BBB-on-a-chip Reveals Barrier Disruption, Endothelial Inflammation, and T-Cell Migration Under Neuroinflammatory Conditions
The First Large-Scale Phenotypic Screen Using Organ-on-a-Chip: A 1537 Kinase Inhibitor Library Screen on a 3D Angiogenesis Assay
MIMETAS and Dundee Placenta Model Could Transform Pregnancy Healthcare
The National Growth Fund Reserves 125 million euros for the Transition to Animal-Free Innovation
MIMETAS and Astellas Expand Partnership to Include Automation and Application Support
No items found...